[1]
2009. Budget impact analysis of the use of rituximab in the treatment of rheumatoid arthritis in Italy. Farmeconomia. Health economics and therapeutic pathways. 10, 1 (Mar. 2009), 19–31. DOI:https://doi.org/10.7175/fe.v10i1.160.